We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




McKesson to Acquire Risk Management Company

By HospiMedica International staff writers
Posted on 05 Oct 2012
McKesson (San Francisco, CA, USA) reported that it has entered into a definitive agreement to acquire MedVentive (Waltham, MA, USA), a provider of population and risk management tools that fuel transparency in healthcare cost and quality. More...


MedVentive’s solutions will enhance McKesson’s capabilities and experience in supporting customers’ use of information technology (IT) to optimize clinical, financial, and operational performance and to coordinate care across settings and stakeholders--areas that are core to McKesson Technology Solutions’ Better Health 2020 strategy.

“More healthcare providers are beginning to assume risk as we move to value-based reimbursement,” said Pat Blake, executive vice president and group president of McKesson Technology Solutions. “Whether it’s for their employee population, a Medicare shared savings plan, or a defined disease state group, providers must understand the risk they are assuming. What providers really need--and McKesson’s solutions will help offer--is a true picture of the total cost of delivered care based on clinical documentation and claims data across all care settings.”

MedVentive’s solutions will be a strong complement to the McKesson Enterprise Intelligence suite of solutions, according to McKesson spokespersons, enabling providers to proactively manage the clinical health of at-risk patient populations by identifying holes in patient care and delivering actionable information to the physician and care team.

Related Links:
McKesson
MedVentive



Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Pedicle Screw Platform
CREO DLX Stabilization System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.